Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity
Creators
- 1. Department of Biochemistry and Cancer Biology, University of Toledo–Health Science Campus, Toledo, OH 43614 (United States)
- 2. Physiological Genomics Laboratory, Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH 43614 (United States)
- 3. Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL 32610 (United States)
Description
Chromatin remodeling complex SWI/SNF plays important roles in many cellular processes including transcription, proliferation, differentiation and DNA repair. In this report, we investigated the role of SWI/SNF catalytic subunits Brg1 and Brm in the cellular response to cisplatin in lung cancer and head/neck cancer cells. Stable knockdown of Brg1 and Brm enhanced cellular sensitivity to cisplatin. Repair kinetics of cisplatin DNA adducts revealed that downregulation of Brg1 and Brm impeded the repair of both intrastrand adducts and interstrand crosslinks (ICLs). Cisplatin ICL-induced DNA double strand break repair was also decreased in Brg1 and Brm depleted cells. Altered checkpoint activation with enhanced apoptosis as well as impaired chromatin relaxation was observed in Brg1 and Brm deficient cells. Downregulation of Brg1 and Brm did not affect the recruitment of DNA damage recognition factor XPC to cisplatin DNA lesions, but affected ERCC1 recruitment, which is involved in the later stages of DNA repair. Based on these results, we propose that SWI/SNF chromatin remodeling complex modulates cisplatin cytotoxicity by facilitating efficient repair of the cisplatin DNA lesions. -- Highlights: ► Stable knockdown of Brg1 and Brm enhances cellular sensitivity to cisplatin. ► Downregulation of Brg1 and Brm impedes the repair of cisplatin intrastrand adducts and interstrand crosslinks. ► Brg1 and Brm deficiency results in impaired chromatin relaxation, altered checkpoint activation as well as enhanced apoptosis. ► Downregulation of Brg1 and Brm affects recruitment of ERCC1, but not XPC to cisplatin DNA lesions.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.yexcr.2012.06.011Additional details
Identifiers
- DOI
- 10.1016/j.yexcr.2012.06.011;
- PII
- S0014-4827(12)00290-X;
Publishing Information
- Journal Title
- Experimental Cell Research
- Journal Volume
- 318
- Journal Issue
- 16
- Journal Page Range
- p. 1973-1986
- ISSN
- 0014-4827
- CODEN
- ECREAL
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45033557
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- APOPTOSIS; CARCINOMAS; CHROMATIN; DNA; DNA ADDUCTS; ENZYME IMMUNOASSAY; ENZYMES; EXCISION REPAIR; HEAD; LUNGS; NECK; NUCLEOTIDES; SENSITIVITY; STRAND BREAKS; TOXICITY; TRANSCRIPTION
- Descriptors DEC
- ADDUCTS; BIOASSAY; BIOLOGICAL RECOVERY; BIOLOGICAL REPAIR; BODY; DISEASES; DNA DAMAGES; DNA REPAIR; IMMUNOASSAY; NEOPLASMS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PROTEINS; REPAIR; RESPIRATORY SYSTEM
Optional Information
- Copyright
- Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.